MedPath

CT-guided selective dorsal root ganglion electroacupuncture in the treatment of postherpetic neuralgia: a randomized controlled trial

Phase 1
Recruiting
Conditions
Postherpetic neuralgia
Registration Number
ITMCTR2000003776
Lead Sponsor
Shanghai Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) The participant participates signed informed consent is required;
(2) Pain that lasts >= 1 month after the shingles rash has healed;
(3) Herpes affects the intercostal nerve;
(4) The participant 's onset time <= 3 months;
(5) The participant is a male or female outpatient aged 50–80 years;
(6) The participant has a VAS score >= 4.

Exclusion Criteria

(1) Occult herpes and visceral nerve herpetic pain;
(2) Leukemia, aplastic anemia, systemic lupus erythematosus, kidney transplantation, liver transplantation, malignant tumor, AIDS;
(3) Abnormal laboratory indicators: Those with ALT, AST, BUN exceeding 20% of the upper limit of normal; those with other clinically significant laboratory indicators abnormal;
(4) Women who are pregnant or breastfeeding, or have pregnancy plans in the past three months;
(5) Allergies;
(6) According to the judgment of the investigator, those who have other diseases that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the working environment, which may easily cause loss to follow-up, and those who cannot give full informed consent due to mental and behavioral disorders;
(7) Patients who participated in other clinical trials within the past month.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ID pain;VAS Score;Substance P;Serum ß-endorphin;
Secondary Outcome Measures
NameTimeMethod
PSQI;SF-36;
© Copyright 2025. All Rights Reserved by MedPath